ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAsBusiness Wire • 04/06/21
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/09/21
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future GrowthBusiness Wire • 03/09/21
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO BusinessBusiness Wire • 03/09/21
Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to DeclineZacks Investment Research • 03/02/21
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 02/19/21
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021Business Wire • 02/16/21
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) CapsulesBusiness Wire • 02/01/21
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid TabletsBusiness Wire • 12/17/20
ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial ResultsBusiness Wire • 10/29/20
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 09/10/20
ANI Pharmaceuticals, Inc. (ANIP) CEO Patrick Walsh on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of DirectorsBusiness Wire • 08/06/20
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive OfficerBusiness Wire • 08/03/20
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial ResultsBusiness Wire • 07/30/20